Four Ways to “Eureka”: How Big Data is Accelerating Biomedical Research

Data is rapidly changing healthcare as more and more stakeholders—providers, patients, and payers—go digital. Researchers are taking advantage of the digital movement as well, exploring the role of informatics in a rapid-learning environment where data flows across the spectrum, from the bedside to the bench, and back again.

HDC logo

To accelerate this vision, FKH has been instrumental in launching the Data Liquidity Coalition, a group dedicated to enabling a rapid learning healthcare environment for cancer and other diseases. We are also proud to be a partner and sponsor of Health Datapalooza IV, the premier national conference on liberating health data to achieve better health outcomes, organized by the Health Data Consortium. This year I’ve organized a panel at the Palooza on Illuminating Disease at the Speed of Light:  How Big Data Is Accelerating Biomedical Research and Development.” As the biomedical field explodes with big-data-related R&D activity, four thought leaders will demonstrate the use online tools to:

  1. Turn large volumes of complex data into actionable information.
  2. Use high-speed genome profiling for quick molecularly-based diagnoses of “mystery” diseases.
  3. Drive a statewide point-of-care quality monitoring program being used by physicians in routine clinical practice, in which data are banked;  used to determine important questions for research; and then picked up by a national clinical trials network and transitioned into clinical trials.
  4. Enable collection and aggregation of data on multiple sclerosis (MS), drive collaborative efforts to analyze markers of MS origins, and discover new therapeutics.

Learn about our speakers here.

You can still register for Health Datapalooza IV. Be sure to join us on Tuesday, June 4.

HDP logo

 

Marcia Kean is chairman, strategic initiatives, at Feinstein Kean Healthcare.